ASF Research Grants support scientists and clinicians studying Angelman syndrome, funding research on UBE3A, therapies, care, and biomarkers to advance treatments and improve quality of life.
The ASF Research Funding Program by the Alport Syndrome Foundation funds innovative basic and clinical research to advance understanding and treatment of Alport syndrome.
The Innovation Seed Grant from FAST funds bold, early-stage research to advance scientific understanding and treatment options for Angelman syndrome.
The FAST Impact Award funds innovative translational research to advance therapies for Angelman syndrome from pre-clinical stages to IND application readiness.
FAST's Postdoctoral Fellowship funds early-career researchers to advance scientific understanding and treatment of Angelman syndrome through mentored, independent research projects.
New Investigator Award supports new academic scientists developing translational Angelman syndrome research and technologies to advance treatment approaches and establish lasting research programs.